RT Journal Article
T1 Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping Review
A1 Sánchez, Cristina
A1 Fente Sampayo, Cristina Asunción
A1 Regal López, Patricia
A1 Lamas Freire, Alexandre
A1 Lorenzo García, María Paz
K1 Breast milk
K1 Breastfeeding
K1 Human milk oligosaccharide
K1 Infant gut microbiota
K1 Microbiome
AB Human milk oligosaccharides (HMOs) are the third most abundant solid component of breast milk. However, the newborn cannot assimilate them as nutrients. They are recognized prebiotic agents (the first in the newborn diet) that stimulate the growth of beneficial microorganisms, mainly the genus Bifidobacterium, dominant in the gut of breastfed infants. The structures of the oligosaccharides vary mainly according to maternal genetics, but also other maternal factors such as parity and mode of delivery, age, diet, and nutritional status or even geographic location and seasonality cause different breast milk oligosaccharides profiles. Differences in the profiles of HMO have been linked to breast milk microbiota and gut microbial colonization of babies. Here, we provide a review of the scope of reports on associations between HMOs and the infant gut microbiota to assess the impact of HMO composition
PB MDPI
YR 2021
FD 2021
LK http://hdl.handle.net/10347/26674
UL http://hdl.handle.net/10347/26674
LA eng
NO Foods 2021, 10(6), 1429; https://doi.org/10.3390/foods10061429
DS Minerva
RD 24 abr 2026